Vivakor
VIVK
#10288
Rank
โ‚น1.12 B
Marketcap
โ‚น6.83
Share price
-14.03%
Change (1 day)
-94.32%
Change (1 year)

Revenue for Vivakor (VIVK)

Revenue in 2025 (TTM): โ‚น10.59 Billion

According to Vivakor's latest financial reports the company's current revenue (TTM ) is โ‚น11.14 Billion. In 2024 the company made a revenue of โ‚น7.70 Billion an increase over the revenue in the year 2023 that were of โ‚น4.93 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vivakor from 2008 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น10.59 B37.53%
2024 โ‚น7.70 B56.01%
2023 โ‚น4.93 B112.33%
2022 โ‚น2.32 B2770.99%
2021 โ‚น81.01 M
2009 โ‚น5.15 M-44.86%
2008 โ‚น9.35 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Merrimack Pharmaceuticals
MACK
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
โ‚น276.88 B 2,384.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
โ‚น8.47 B-23.97%๐Ÿ‡บ๐Ÿ‡ธ USA